[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Genmab A/S Genmab's stock is up after strong Q3 sales and the acquisition of Merus for $X billion. The company's positive momentum is driven by FDA breakthroughs and strategic moves. ### About Genmab A/S Genmab A/S is a biotechnology company focused on the development of antibody therapeutics for the treatment of cancer. ### Insights [#](/topic/$gmabco/insights) - Genmab A/S Price hit a 52-Week high of XXXXX for the hour ### Price: $ [#](/topic/$gmabco/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$gmabco/time-series/close.tsv) The price is likely experiencing positive momentum due to the FDA breakthrough designation, strong revenue growth, and strategic acquisitions, despite the undefined market cap and recent 52-week high. **1-Year High**: $XXXXX on 2025-10-16 **1-Year Low**: $XXXXXXXX on 2025-04-09 ### AltRank: undefined [#](/topic/$gmabco/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$gmabco/time-series/alt_rank.tsv) Genmab A/S is currently AltRank #undefined based on combined combined social and market metrics **Daily Average**: XXX **1-Year High**: XXX on 2024-10-20 **1-Year Low**: XXX on 2025-03-03 ### Galaxy Score: XX [#](/topic/$gmabco/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$gmabco/time-series/galaxy_score.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XX on 2025-09-29 **1-Year Low**: X on 2025-08-01 ### Engagements: XXXXX [#](/topic/$gmabco/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$gmabco/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXXXXX +246% **6 Months**: XXXXXXXXX +67% **1 Year**: XXXXXXXXX +170% **1-Year High**: XXXXXXX on 2025-09-29 **1-Year Low**: XXX on 2024-10-20 | Social Network | Reddit | TikTok | X | News | YouTube | | -------------- | ------ | ------ | - | ---- | ------- | | Engagements | XXX | XXX | XXXXX | XX | XXXXX | ### Mentions: XXX [#](/topic/$gmabco/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$gmabco/time-series/posts_active.tsv) **Current Value**: XXX **Daily Average**: XX **6 Months**: XXXXX +18% **1 Year**: XXXXX +114% **1-Year High**: XXX on 2025-09-29 **1-Year Low**: X on 2025-01-27 | Social Network | Reddit | TikTok | X | News | YouTube | | -------------- | ------ | ------ | - | ---- | ------- | | Mentions | XX | X | XXX | X | XX | ### Creators: XX [#](/topic/$gmabco/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$gmabco/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Genmab A/S in the last XX hours which is down XX% from XXX in the previous XX hours **Daily Average**: XX **6 Months**: XXX +8.30% **1 Year**: XXX +71% **1-Year High**: XXX on 2025-09-29 **1-Year Low**: X on 2025-01-27 The most influential creators that mention Genmab A/S in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Genmab](/creator/twitter/Genmab) | X | XXXXX | XX | XXX | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X | XXXXX | X | XXX | | [@H2AK119ub](/creator/reddit/H2AK119ub) | X | | X | XXX | | [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) | X | XXX | X | XX | | [@MichelleF_Davis](/creator/twitter/MichelleF_Davis) | X | XXXXX | X | XX | | [@HottestStockNow](/creator/twitter/HottestStockNow) | X | XXXXX | X | XX | | [@patientstory](/creator/tiktok/patientstory) | X | XXXXXX | X | XX | | [@business](/creator/twitter/business) | X | XXXXXXXXXXX | X | XX | | [@BioNJ_Org](/creator/twitter/BioNJ_Org) | X | XXXXX | X | XX | | [@investseekers](/creator/twitter/investseekers) | XX | XXXXX | X | XX | [View More](/list/creators/$gmabco/100) ### Sentiment: XX% [#](/topic/$gmabco/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$gmabco/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -XX% **1 Month**: XX% +2% **6 Months**: XX% -XX% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2024-11-01 **1-Year Low**: XX% on 2025-03-25 **Most Supportive Themes** - **FDA Breakthrough Designation and Pipeline Progress:** (40%) Positive news regarding Rina-S and overall pipeline advancements. - **Revenue Growth and Financial Performance:** (30%) Strong revenue growth driven by royalties and self-commercialized drugs. - **Strategic Moves and Acquisitions:** (15%) Acquisition of ProfoundBio to expand presence in the antibody-drug conjugate market. **Most Critical Themes** - **Market Cap Uncertainty:** (5%) Market Cap is currently undefined. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | Reddit | XXX | X% | XXX | X% | XX | X% | | TikTok | XX | X% | XXX | X% | X | X% | | X | XXX | XX% | XXXXX | XX% | XX | X% | | News | X | X% | XX | X% | X | X% | | YouTube | XXXXX | XX% | XX | X% | X | X% | | | | | | | | | | Total | XXXXX | XX% | XXXXX | XX% | XX | X% | ### Market Cap: $undefined [#](/topic/$gmabco/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$gmabco/time-series/market_cap.tsv) **Current Value**: $undefined **Daily Average**: $XXXXXXXXXXXXXX **1-Year High**: $XXXXXXXXXXXXXXX on 2025-03-07 **1-Year Low**: $XXXXXXXXXXXXXX on 2025-04-01 **Top assets mentioned** In the posts about Genmab A/S in the last XX hours [Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Innovative Solutions & Support (ISSC)](/topic/$issc) [AbbVie Inc (ABBV)](/topic/$abbv) [Novartis AG (NVS)](/topic/novartis) [Pfizer, Inc. (PFE)](/topic/$pfe) [Johnson & Johnson (JNJ)](/topic/$jnj) [AstraZeneca PLC (AZN)](/topic/$azn) [Sanofi (SNY)](/topic/sanofi) [Merck & Co., Inc. (MRK)](/topic/$mrk) **Top topics mentioned** In the posts about Genmab A/S in the last XX hours [$gmab](/topic/$gmab), [$mrus](/topic/$mrus), [stocks healthcare](/topic/stocks-healthcare), [stocks](/topic/stocks), [$8b](/topic/$8b), [acquisition](/topic/acquisition), [stocks technology](/topic/stocks-technology), [$novcde](/topic/$novcde), [johnson johnson](/topic/johnson-johnson), [investment](/topic/investment), [$issc](/topic/$issc), [$abbv](/topic/$abbv), [novartis](/topic/novartis), [novo](/topic/novo), [$novnsw](/topic/$novnsw), [$pfe](/topic/$pfe), [$jnj](/topic/$jnj), [upside](/topic/upside), [breakthrough](/topic/breakthrough), [stocks financial services](/topic/stocks-financial-services), [denmark](/topic/denmark), [stocks communication services](/topic/stocks-communication-services), [people with](/topic/people-with), [$azn](/topic/$azn), [danish krone](/topic/danish-krone), [sanofi](/topic/sanofi), [af](/topic/af), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [targets](/topic/targets), [$mrk](/topic/$mrk), [$18b](/topic/$18b), [bloomberg](/topic/bloomberg), [taiwan semiconductor](/topic/taiwan-semiconductor), [royalty](/topic/royalty), [longterm](/topic/longterm), [$pypl](/topic/$pypl), [$deo](/topic/$deo), [$xbi](/topic/$xbi), [$80b](/topic/$80b), [breaking news](/topic/breaking-news), [summary](/topic/summary), [ticker](/topic/ticker), [electronic arts inc](/topic/electronic-arts-inc), [ethan](/topic/ethan), [strikes](/topic/strikes), [donald trump](/topic/donald-trump), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [$54share](/topic/$54share), [$52b](/topic/$52b), [power play](/topic/power-play), [$novob](/topic/$novob), [$dsv](/topic/$dsv), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$argx](/topic/$argx), [quarterly earnings](/topic/quarterly-earnings), [og](/topic/og), [$97share](/topic/$97share), [$367b](/topic/$367b), [france](/topic/france), [netherlands](/topic/netherlands), [$ftnt](/topic/$ftnt), [$cdns](/topic/$cdns), [stellantis](/topic/stellantis), [paycom](/topic/paycom), [$googl](/topic/$googl), [$nvo](/topic/$nvo), [make a](/topic/make-a), [hosted](/topic/hosted), [discount](/topic/discount), [microsoft](/topic/microsoft), [$glpgas](/topic/$glpgas), [combo](/topic/combo), [patreon](/topic/patreon), [all the](/topic/all-the), [#ai](/topic/#ai), [rival](/topic/rival), [allegations](/topic/allegations), [carr](/topic/carr), [click the](/topic/click-the), [medtronic](/topic/medtronic), [$hca](/topic/$hca), [$isrg](/topic/$isrg), [$pmeax](/topic/$pmeax), [kla corp](/topic/kla-corp), [ares capital corp](/topic/ares-capital-corp), [procter gamble](/topic/procter-gamble), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$9700shr](/topic/$9700shr), [dp](/topic/dp), [headlines](/topic/headlines), [$crbu](/topic/$crbu), [dd](/topic/dd), [$97shr](/topic/$97shr), [davis](/topic/davis), [$dwtx](/topic/$dwtx), [te](/topic/te), [iii](/topic/iii), [corporate finance](/topic/corporate-finance), [day of](/topic/day-of), [$ea](/topic/$ea) ### Top Social Posts [#](/topic/$gmabco/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$GMAB Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Updated data from the Phase 1/2 RAINFOL-01 trial showed rinatabart sesutecan (Rina-S) XXX mg/m2 demonstrated 50%confirmed objective response rate (ORR) including two complete responses (CR) regardless of FR expression - A Phase X trial in endometrial cancer is underway U.S. FDA recently granted Breakthrough Therapy Designation to Rina-S for advanced endometrial cancer" [X Link](https://x.com/MarcJacksonLA/status/1979640271005724830) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-18T20:06Z 7575 followers, XXX engagements "Genmab: Investigational Rinatabart Sesutecan (Rina-S) Achieves Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer $GMAB #Genmab" [X Link](https://x.com/HottestStockNow/status/1979573337409122684) [@HottestStockNow](/creator/x/HottestStockNow) 2025-10-18T15:40Z 2717 followers, XXX engagements "We presented new data evaluating our investigational therapy in #GynecologicOncology at the @myESMO #ESMO25 Congress. Our latest data underscore our commitment to deliver on our vision and accelerate our late-stage pipeline of #AntibodyMedicines for patients seeking potential new options. Read more:" [X Link](https://x.com/Genmab/status/1979495769385099436) [@Genmab](/creator/x/Genmab) 2025-10-18T10:32Z 7988 followers, XXX engagements "Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer" [Reddit Link](https://redd.it/1o9rvhn) [@Quantisnow](/creator/reddit/Quantisnow) 2025-10-18T10:11Z X followers, X engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Genmab A/S
Genmab's stock is up after strong Q3 sales and the acquisition of Merus for $X billion. The company's positive momentum is driven by FDA breakthroughs and strategic moves.
About Genmab A/S
Genmab A/S is a biotechnology company focused on the development of antibody therapeutics for the treatment of cancer.
Insights #
- Genmab A/S Price hit a 52-Week high of XXXXX for the hour
Price: $ #
Price 24-Hour Time-Series Raw Data
The price is likely experiencing positive momentum due to the FDA breakthrough designation, strong revenue growth, and strategic acquisitions, despite the undefined market cap and recent 52-week high.
1-Year High: $XXXXX on 2025-10-16
1-Year Low: $XXXXXXXX on 2025-04-09
AltRank: undefined #
AltRank 24-Hour Time-Series Raw Data
Genmab A/S is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXX on 2024-10-20
1-Year Low: XXX on 2025-03-03
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-09-29
1-Year Low: X on 2025-08-01
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXXXX +246%
6 Months: XXXXXXXXX +67%
1 Year: XXXXXXXXX +170%
1-Year High: XXXXXXX on 2025-09-29
1-Year Low: XXX on 2024-10-20
| Social Network | TikTok | X | News | YouTube | |
|---|---|---|---|---|---|
| Engagements | XXX | XXX | XXXXX | XX | XXXXX |
Mentions: XXX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
6 Months: XXXXX +18%
1 Year: XXXXX +114%
1-Year High: XXX on 2025-09-29
1-Year Low: X on 2025-01-27
| Social Network | TikTok | X | News | YouTube | |
|---|---|---|---|---|---|
| Mentions | XX | X | XXX | X | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Genmab A/S in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XX
6 Months: XXX +8.30%
1 Year: XXX +71%
1-Year High: XXX on 2025-09-29
1-Year Low: X on 2025-01-27
The most influential creators that mention Genmab A/S in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Genmab | X | XXXXX | XX | XXX |
| @MarcJacksonLA | X | XXXXX | X | XXX |
| @H2AK119ub | X | X | XXX | |
| @EgidiusLambrech | X | XXX | X | XX |
| @MichelleF_Davis | X | XXXXX | X | XX |
| @HottestStockNow | X | XXXXX | X | XX |
| @patientstory | X | XXXXXX | X | XX |
| @business | X | XXXXXXXXXXX | X | XX |
| @BioNJ_Org | X | XXXXX | X | XX |
| @investseekers | XX | XXXXX | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +2%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-11-01
1-Year Low: XX% on 2025-03-25
Most Supportive Themes
- FDA Breakthrough Designation and Pipeline Progress: (40%) Positive news regarding Rina-S and overall pipeline advancements.
- Revenue Growth and Financial Performance: (30%) Strong revenue growth driven by royalties and self-commercialized drugs.
- Strategic Moves and Acquisitions: (15%) Acquisition of ProfoundBio to expand presence in the antibody-drug conjugate market.
Most Critical Themes
- Market Cap Uncertainty: (5%) Market Cap is currently undefined.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| XXX | X% | XXX | X% | XX | X% | |
| TikTok | XX | X% | XXX | X% | X | X% |
| X | XXX | XX% | XXXXX | XX% | XX | X% |
| News | X | X% | XX | X% | X | X% |
| YouTube | XXXXX | XX% | XX | X% | X | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XX | X% |
Market Cap: $undefined #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-07
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-01
Top assets mentioned In the posts about Genmab A/S in the last XX hours
Merus N.V. Common Shares (MRUS) Johnson & Johnson (JNJ) Innovative Solutions & Support (ISSC) AbbVie Inc (ABBV) Novartis AG (NVS) Pfizer, Inc. (PFE) Johnson & Johnson (JNJ) AstraZeneca PLC (AZN) Sanofi (SNY) Merck & Co., Inc. (MRK)
Top topics mentioned In the posts about Genmab A/S in the last XX hours
$gmab, $mrus, stocks healthcare, stocks, $8b, acquisition, stocks technology, $novcde, johnson johnson, investment, $issc, $abbv, novartis, novo, $novnsw, $pfe, $jnj, upside, breakthrough, stocks financial services, denmark, stocks communication services, people with, $azn, danish krone, sanofi, af, stocks consumer cyclical, targets, $mrk, $18b, bloomberg, taiwan semiconductor, royalty, longterm, $pypl, $deo, $xbi, $80b, breaking news, summary, ticker, electronic arts inc, ethan, strikes, donald trump, akro akero therapeutics inc, $54share, $52b, power play, $novob, $dsv, stocks bitcoin treasuries, $argx, quarterly earnings, og, $97share, $367b, france, netherlands, $ftnt, $cdns, stellantis, paycom, $googl, $nvo, make a, hosted, discount, microsoft, $glpgas, combo, patreon, all the, #ai, rival, allegations, carr, click the, medtronic, $hca, $isrg, $pmeax, kla corp, ares capital corp, procter gamble, stocks consumer defensive, $9700shr, dp, headlines, $crbu, dd, $97shr, davis, $dwtx, te, iii, corporate finance, day of, $ea
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$GMAB Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Updated data from the Phase 1/2 RAINFOL-01 trial showed rinatabart sesutecan (Rina-S) XXX mg/m2 demonstrated 50%confirmed objective response rate (ORR) including two complete responses (CR) regardless of FR expression - A Phase X trial in endometrial cancer is underway U.S. FDA recently granted Breakthrough Therapy Designation to Rina-S for advanced endometrial cancer"
X Link @MarcJacksonLA 2025-10-18T20:06Z 7575 followers, XXX engagements
"Genmab: Investigational Rinatabart Sesutecan (Rina-S) Achieves Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer $GMAB #Genmab"
X Link @HottestStockNow 2025-10-18T15:40Z 2717 followers, XXX engagements
"We presented new data evaluating our investigational therapy in #GynecologicOncology at the @myESMO #ESMO25 Congress. Our latest data underscore our commitment to deliver on our vision and accelerate our late-stage pipeline of #AntibodyMedicines for patients seeking potential new options. Read more:"
X Link @Genmab 2025-10-18T10:32Z 7988 followers, XXX engagements
"Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer"
Reddit Link @Quantisnow 2025-10-18T10:11Z X followers, X engagements